Canada markets close in 1 hour 58 minutes

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2900-0.1100 (-3.24%)
As of 02:00PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 144.31M
Enterprise Value -75.90M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.80
Price/Book (mrq)0.68
Enterprise Value/Revenue -1.48
Enterprise Value/EBITDA 0.66

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52-Week Change 3-67.71%
S&P500 52-Week Change 325.77%
52 Week High 313.8500
52 Week Low 32.9800
50-Day Moving Average 34.5776
200-Day Moving Average 36.7297

Share Statistics

Avg Vol (3 month) 3126.83k
Avg Vol (10 day) 3129.87k
Shares Outstanding 542.45M
Implied Shares Outstanding 643.07M
Float 815.09M
% Held by Insiders 11.02%
% Held by Institutions 193.64%
Shares Short (Apr 15, 2024) 4608.26k
Short Ratio (Apr 15, 2024) 45.8
Short % of Float (Apr 15, 2024) 42.37%
Short % of Shares Outstanding (Apr 15, 2024) 41.43%
Shares Short (prior month Mar 15, 2024) 4658.55k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -183.43%
Operating Margin (ttm)-236.58%

Management Effectiveness

Return on Assets (ttm)-23.51%
Return on Equity (ttm)-38.16%

Income Statement

Revenue (ttm)51.13M
Revenue Per Share (ttm)1.22
Quarterly Revenue Growth (yoy)-28.30%
Gross Profit (ttm)N/A
EBITDA -114.27M
Net Income Avi to Common (ttm)-93.8M
Diluted EPS (ttm)-2.2300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)223.63M
Total Cash Per Share (mrq)5.3
Total Debt (mrq)3.41M
Total Debt/Equity (mrq)1.61%
Current Ratio (mrq)6.24
Book Value Per Share (mrq)5.03

Cash Flow Statement

Operating Cash Flow (ttm)-127.16M
Levered Free Cash Flow (ttm)-97.36M